AMH and hypertensive disorder: The pathological features include a decrease in antral follicle count (AFC) and anti-Mullerian hormone (AMH) levels within six months postoperatively, which can also be evidenced by various menopausal symptoms, bone loss, and increased risk of hypertension (41–43).